![conference banner](/images/conference-banner.jpeg)
Abstract
Resveratrol, a polyphenolic phytoalexin, is a very effective antioxidant that also exhibits strong antiproliferative and anti-inflammatory properties. Recent studies have provided support for the use of resveratrol in human cancer chemoprevention, in combination with either chemotherapeutic drugs or cytotoxic factors for a most efficient treatment of drug refractory tumor cells. Resveratrol is also widely used in topical preparations, as a chemoprotective compound against development of several cutaneous disorders, including skin cancer. Nevertheless, the combined effect of resveratrol and UVA irradiation on cellular toxicity and DNA damage has never been assessed. The aim of this work was to investigate the effect of resveratrol on cell fate in immortalized human keratinocytes HaCaT cells. The results indicated that resveratrol potentiates the production of significant amounts of 8-oxo-7,8-dihydro-2- deoxyguanosine in UVA-irradiated genomic DNA. Moreover, the combination of resveratrol with UVA significantly enhances the induction of DNA strand breaks and cell death in HaCaT keratinocytes. The conclusion is a potential hazardous effect of topical application of resveratrol, particularly on regions exposed to sunlight.
Keywords: UVA-induced DNA damage, MTT assay, phytoalexin, Irradiation, alkali-labile sites, colonic tumor cells
Medicinal Chemistry
Title: Resveratrol Enhances UVA-Induced DNA Damage in HaCaT Human Keratinocytes
Volume: 1 Issue: 6
Author(s): M. Seve, F. Chimienti, S. Devergnas, M. Aouffen, T. Douki, J. Chantegrel, J. Cadet and A. Favier
Affiliation:
Keywords: UVA-induced DNA damage, MTT assay, phytoalexin, Irradiation, alkali-labile sites, colonic tumor cells
Abstract: Resveratrol, a polyphenolic phytoalexin, is a very effective antioxidant that also exhibits strong antiproliferative and anti-inflammatory properties. Recent studies have provided support for the use of resveratrol in human cancer chemoprevention, in combination with either chemotherapeutic drugs or cytotoxic factors for a most efficient treatment of drug refractory tumor cells. Resveratrol is also widely used in topical preparations, as a chemoprotective compound against development of several cutaneous disorders, including skin cancer. Nevertheless, the combined effect of resveratrol and UVA irradiation on cellular toxicity and DNA damage has never been assessed. The aim of this work was to investigate the effect of resveratrol on cell fate in immortalized human keratinocytes HaCaT cells. The results indicated that resveratrol potentiates the production of significant amounts of 8-oxo-7,8-dihydro-2- deoxyguanosine in UVA-irradiated genomic DNA. Moreover, the combination of resveratrol with UVA significantly enhances the induction of DNA strand breaks and cell death in HaCaT keratinocytes. The conclusion is a potential hazardous effect of topical application of resveratrol, particularly on regions exposed to sunlight.
Export Options
About this article
Cite this article as:
Seve M., Chimienti F., Devergnas S., Aouffen M., Douki T., Chantegrel J., Cadet J. and Favier A., Resveratrol Enhances UVA-Induced DNA Damage in HaCaT Human Keratinocytes, Medicinal Chemistry 2005; 1 (6) . https://dx.doi.org/10.2174/157340605774598144
DOI https://dx.doi.org/10.2174/157340605774598144 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
![Wayfinder Image](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Systemic Involvement of IgG4-related Sclerosing Disease
Current Immunology Reviews (Discontinued) Recent Advances in Image-Based Stem-Cell Labeling and Tracking, and Scaffold-Based Organ Development in Cardiovascular Disease
Recent Patents on Medical Imaging Physical Means of Stratum Corneum Barrier Manipulation to Enhance Transdermal Drug Delivery
Current Drug Delivery Current Status of Newer Antiinfectives
Recent Patents on Anti-Infective Drug Discovery The Targeted-liposome Delivery System of Antitumor Drugs
Current Drug Metabolism Lipid Matrix Nanoparticles: Pharmacokinetics and Biopharmaceutics
Current Nanoscience Resveratrol and Cardiovascular Disease
Current Nutrition & Food Science Nucleic Acids Electrotransfer In Vivo: Mechanisms and Practical Aspects
Current Gene Therapy Targeting the EGF/HER Ligand-Receptor System in Cancer
Current Pharmaceutical Design Myelodysplastic Syndromes: Review of Pathophysiology and Current Novel Treatment Approaches
Current Cancer Drug Targets An Overview on Inventions Related to Ginger Processing and Products for food and Pharmaceutical Applications
Recent Patents on Food, Nutrition & Agriculture Renin-angiotensin System Blockers and Modulation of Radiation-Induced Brain Injury
Current Drug Targets Advances in the Treatment of Ovarian Cancer Using PARP Inhibitors and the Underlying Mechanism of Resistance
Current Drug Targets The Proteasome as a Therapeutic Target for Lung Fibrosis
Current Enzyme Inhibition A Review of the Occurrence of Rheumatoid Arthritis and Potential Treatments through Medicinal Plants from an Indian Perspective
Current Rheumatology Reviews Birt-hogg-Dubé Syndrome Incidentally Identified in a Potential Liver Donor
Current Medical Imaging Neuropilin Signalling in Vascular Development and Pathology
Current Angiogenesis (Discontinued) Treatment of Leishmaniasis: A Review and Assessment of Recent Research
Current Pharmaceutical Design Role of Graphene Nano-Composites in Cancer Therapy: Theranostic Applications, Metabolic Fate and Toxicity Issues
Current Drug Metabolism Biomarkers for Risk Assessment and Prevention of Breast Cancer
Current Cancer Drug Targets